Skip to content

Antithrombin III Screen Kit

by Pacific Hemostasis

510(k) K812215

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK812215 Date1 Sep 1981ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 5 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JBQ
Device Class
Class II
Regulation
21 CFR Part 864.7060
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Antithrombin III Screen Kit is an in vitro diagnostic device classified as a quantitation reagent for measuring antithrombin III levels in plasma. It is designed to assist in the diagnosis and monitoring of conditions associated with antithrombin deficiency, such as hereditary antithrombin deficiency or acquired antithrombin deficiency, which may predispose patients to thrombotic events. The kit provides quantitative results to evaluate coagulation function and support clinical decision-making in hematology.

This kit is supplied as a single-use reagent system for laboratory use, requiring no special storage conditions beyond refrigeration at 2–8°C. It is intended for use in clinical laboratories with appropriate instrumentation, such as coagulation analyzers, and adheres to FDA 510(k) clearance under the Hematology advisory committee. The product code JBQ and regulation number 864.7060 further classify it as a Class II device under the FDA’s regulatory framework. No MRI safety considerations apply, as it is not intended for use in magnetic resonance environments.

Other devices from Pacific Hemostasis

See all devices from Pacific Hemostasis →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Antithrombin III Screen Kit used for?

    The Antithrombin III Screen Kit is designed to measure antithrombin III levels in plasma, helping clinicians diagnose and monitor conditions like hereditary or acquired antithrombin deficiency. These deficiencies can increase the risk of thrombotic events, so accurate quantitation supports informed decision-making in hematology.

  • How is the Antithrombin III Screen Kit supplied and stored?

    The kit is supplied as a single-use reagent system intended for laboratory use. It requires standard refrigeration between 2–8°C and does not need additional storage precautions. This ensures stability and reliability for quantitative testing in clinical settings.

  • Is the Antithrombin III Screen Kit intended for reuse or single-use?

    The kit is explicitly designed for single-use only. This prevents cross-contamination and maintains accuracy in measuring antithrombin III levels, adhering to best practices for in vitro diagnostic devices.

  • What type of instrumentation is required to use the Antithrombin III Screen Kit?

    The kit is intended for use in clinical laboratories equipped with coagulation analyzers. These analyzers are standard in hematology settings and ensure precise quantitation of antithrombin III, enabling reliable clinical assessment.

  • Does the Antithrombin III Screen Kit have any special regulatory considerations?

    The kit holds FDA 510(k) clearance under the Hematology advisory committee and is classified as a Class II device (product code JBQ, regulation number 864.7060). No MRI safety concerns apply, as it is not intended for use in magnetic resonance environments.